US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke: Medical therapy in patients with carotid artery stenosis

Stroke

Volumn 27, Issue 9, 1996, Pages 1473-1478

  Goldstein, Larry B ^a,b,e   Bonito, Arthur J ^a,c   Matchar, David B ^a   Duncan, Pamela W ^a,d   Samsa, Gregory P ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

^c RTI INTERNATIONAL   (United States)

^d UNIVERSITY OF KANSAS   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

anticoagulants; antiplatelet agents; aspirin; carotid stenosis; stroke prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; HUMAN; MEDICAL SPECIALIST; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURGEON; UNITED STATES;

EID: 0029839694     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.9.1473     Document Type: Article

References (20)

1. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81-106.
2. Goldstein LB, Bonito AJ, Matchar DB, Duncan PW, DeFriese GH, Oddone EZ, Paul JE, Akin DR, Samsa GP. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke: design, service availability, and common practices. Stroke. 1995;26:1607-1615.
3. Atrial Fibrillation Investigators: Atrial Fibrillation Aspirin, Anticoagulation Study, Boston Area Anticoagulation Trial for Atrial Fibrillation Study. Canadian Atrial Fibrillation Anticoagulation Study, Stroke Prevention in Atrial Fibrillation Study, Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Study. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449-1457.
4. Feinberg WM, Albers GW, Barnett HJM, Biller J, Caplan LR, Carter LP, Hart RG, Hobson RW II, Kronmal RA, Moore WS, Robertson JT, Adams HP Jr, Mayberg M. Guidelines for the management of transient ischemic attacks: from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association. Stroke. 1994;25:1320-1335.
5. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991; 325:445-453.
6. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet. 1991;337:1235-1243.
7. Mayberg MR, Wilson E, Yatsu F, Weiss DG, Messina L, Hershey LA, Colling C, Eskridge J, Deykin D, Winn R. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. JAMA. 1991;266:3289-3294.
8. Hobson RW II, Weiss DG, Fields WS, Goldstone J, Moore WS, Towne JB, Wright CB, VA Coop Study Group. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med. 1993;328:221-227.
9. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421-1428.
10. Rothwell PM, Warlow CP. The European Carotid Surgery Trial (ECST). In: Greenhalgh RM, Hollier LH, eds. Surgery for Stroke. London, England: WB Saunders; 1993:369-381.
11. Marsh EE III, Adams HP Jr, Biller J, Wasek P, Banwart K, Mitchell V, Woolson R. Use of antithrombotic drugs in the treatment of acute ischemic stroke: a survey of neurologists in practice in the United States. Neurology. 1989;39:1631-1634.
12. Goldstein LB, Bonito AJ, Matchar DB, Duncan PW, Samsa GP. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke: carotid endarterectomy. Stroke. 1996;27:801-806.
13. Shah BV, Barnwell BG, Hunt PN, LaVange LM. SUDAAN User's Manual, Release 6.00. Research Triangle Park, NC: Research Triangle Institute; 1992.
14. Barnwell BG, Bieler GS, Shah BV. SUDAAN Technical Report: The MULTILOG Procedure, Release 6.6. Research Triangle Park, NC: Research Triangle Institute; 1996.
15. Heyman A, Wilkinson WE, Heyden S, Helms MJ, Bartel AG, Karp HR, Tyroller HA, Hames CG. Risk of stroke in asymptomatic persons with cervical arterial bruits. N Engl J Med. 1980;302:838-841.
16. Chambers BR, Norris JW. Outcome in patients with asymptomatic neck bruits. N Engl J Med. 1986;315:860-865.
17. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ. 1988;296: 320-331.
18. Mayo Asymptomatic Carotid Endarterectomy Study Group: results of a randomized controlled trial of carotid endarterectomy for asymptomatic carotid stenosis. Mayo Clin Proc. 1992;67:513-518.
19. Lindblad B, Persson NH, Takolander R, Bergqvist D. Does lowdose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial. Stroke. 1993;24: 1125-1128.
20. Montano DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health. 1995;85: 795-800.